Lipidomic analysis reveals alterations in hepatic FA profile associated with MASLD stage in patients with obesity.

María Ángeles Núñez-SánchezMaría Antonia Martinez-SanchezJosé Ignacio Martínez-MontoroAndrés Balaguer-RománElena Murcia-GarcíaVirginia Esperanza Fernández-RuizMercedes Ferrer-GómezCarlos Manuel Martínez-CáceresTomasz SledzinskiMaría Dolores FrutosJuan José Hernández-MoranteJosé Carlos Fernández-GarcíaMaría Isabel Queipo-OrtuñoAntonio José Ruiz-AlcarazAdriana MikaBruno Ramos-Molina

Published in: The Journal of clinical endocrinology and metabolism (2024)

Alterations in hepatic FA levels in MASLD patients were due to an enhancement of the de novo lipogenesis in the liver.

Keyphrases

end stage renal disease
ejection fraction
metabolic syndrome
chronic kidney disease
type diabetes
insulin resistance
high fat diet induced
weight loss
peritoneal dialysis
patient reported outcomes
skeletal muscle